145 results
Keyword Paliperidone Teva Remove keyword
-
List item
Paediatric Committee (PDCO): 17-20 January 2023 (updated)
Virtual meeting, from 17/01/2023 to 20/01/2023, Last updated: 17/01/2023 -
List item
Paediatric Committee (PDCO): 6-8 February 2013
European Medicines Agency, London, UK, from 06/02/2013 to 08/02/2013, Last updated: 21/12/2010 -
List item
Paediatric Committee (PDCO): 13-16 December 2022
Virtual meeting, from 13/12/2022 to 16/12/2022, Last updated: 13/12/2022 -
List item
Paediatric Committee (PDCO): 6-9 September 2022
Virtual meeting, from 06/09/2022 to 09/09/2022, Last updated: 26/10/2022 -
List item
Management Board meeting: 4-5 March 2009
European Medicines Agency, London, UK, from 04/03/2009 to 05/03/2009, Last updated: 01/09/2011 -
List item
Press release: Meeting highlights from the Paediatric Committee: 13 - 15 February 2008
PDCO, Last updated: 27/03/2008infectious diseases; Paliperidone, from Janssen Cilag International … -
List item
Management Board meeting: 17 March 2016
European Medicines Agency, London, UK, 17/03/2016, Last updated: 19/06/2014 -
List item
Press release: Meeting highlights from the Paediatric Committee: 9 - 11 April 2008
PDCO, Last updated: 15/04/2008adopted decisions on PIPs for paliperidone and doripenem monohydrate … -
List item
Management Board meeting: 7 October 2021
European Medicines Agency, Amsterdam, the Netherlands, 07/10/2021, Last updated: 18/01/2022 -
List item
Paediatric Committee (PDCO): 13-16 October 2020
Virtual meeting, from 13/10/2020 to 16/10/2020, Last updated: 14/12/2020 -
List item
Paediatric Committee (PDCO): 12-15 December 2017
European Medicines Agency, London, UK, from 12/12/2017 to 15/12/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 18-21 April 2017
European Medicines Agency, London, UK, from 18/04/2017 to 21/04/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 17-19 August 2016
European Medicines Agency, London, UK, from 17/08/2016 to 19/08/2016, Last updated: 17/08/2016EMEA-001202-PIP02-13-M01, from Teva Pharmaceuticals Europe, for … -
List item
Paediatric Committee (PDCO): 20-22 July 2016
European Medicines Agency, London, UK, from 20/07/2016 to 22/07/2016, Last updated: 04/08/2016 -
List item
Paediatric Committee (PDCO): 7-10 November 2017
European Medicines Agency, London, UK, from 07/11/2017 to 10/11/2017, Last updated: 03/07/2014EMEA-001877-PIP03-17, from Teva Pharma GmbH, for prevention … -
List item
Paediatric Committee (PDCO): 16-19 May 2017
European Medicines Agency, London, UK, from 16/05/2017 to 19/05/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 12-14 August 2015
European Medicines Agency, London, UK, from 12/08/2015 to 14/08/2015, Last updated: 19/02/2013 -
List item
Paediatric Committee (PDCO): 21-24 March 2017
European Medicines Agency, London, UK, from 21/03/2017 to 24/03/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 12-15 September 2017
European Medicines Agency, London, UK, from 12/09/2017 to 15/09/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 15-18 August 2017
European Medicines Agency, London, UK, from 15/08/2017 to 18/08/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 18-21 July 2017
European Medicines Agency, London, UK, from 18/07/2017 to 21/07/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 14-16 September 2016
European Medicines Agency, London, UK, from 14/09/2016 to 16/09/2016, Last updated: 30/06/2014